Retatrutide 30mg

Retatrutide 30mg is a high-purity research-grade triple agonist peptide (GLP-1, GIP, and glucagon receptors) offered in a 30mg vial for metabolic and energy-balance research. Every batch is HPLC-tested and ships with a batch-specific third-party Certificate of Analysis (COA) confirming identity and 99%+ purity. For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.

Research Applications

Retatrutide is widely referenced in triple-incretin metabolic research. Investigators use it in in-vitro and preclinical models to examine combined GLP-1, GIP, and glucagon receptor signaling, energy expenditure, and lipid handling. The 30mg vial suits smaller studies and initial characterization work.

Purity & Verification

Every lot is analyzed by reversed-phase HPLC and, where applicable, mass spectrometry to confirm compound identity and 99%+ purity. A batch-specific, third-party Certificate of Analysis (COA) is included in the product gallery so researchers can confirm purity and identity before use. Supplied as a lyophilized (freeze-dried) powder; store sealed, cool, dry, and protected from light, and reconstitute per standard laboratory handling. Fast, tracked shipping from within the United States.

Peptide Research & Literature

Retatrutide is studied in peer-reviewed clinical trial literature as a triple-hormone receptor agonist. Selected published literature includes:

• Jastreboff AM, et al. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial." New England Journal of Medicine, 2023. PMID: 37366315
• Bajaj HS, et al. "Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial." The Lancet, 2026. PMID: 42250575

These citations are provided for research reference only and do not imply any claim about the effects of this product.

Frequently Asked Questions

What is Retatrutide studied for?
Combined GLP-1/GIP/glucagon receptor activation and metabolic endpoints, strictly in laboratory research settings.

How pure is Kynetide Retatrutide?
99%+ HPLC-verified purity, documented in a batch-specific third-party COA.

Do you provide a COA?
Yes, a lot-specific third-party COA is included in the product gallery.

Is this a supplement or drug?
No. It is a research chemical for laboratory use only, not for human consumption.

What documentation comes with each order?
Each order includes a batch-specific third-party Certificate of Analysis confirming HPLC purity and identity.

Is this the same compound referenced in the published research literature?
Yes. Retatrutide is the same triple GIP/GLP-1/glucagon receptor agonist studied in the peer-reviewed clinical trial literature cited above.

For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.